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We showed previously that infection of herpes simplex virus type 1 (HSV-1) rapidly induced the suppressor of cytokine signaling-3
(SOCS3), a host negative regulator of the JAK/STAT pathway, in the amnion cell line FL. Thus, HSV-1 suppresses the interferon (IFN)
signaling pathway at the step of IFN-induced phosphorylation of janus kinases during an early infection stage. In the present study, we
examined SOCS3 induction by HSV-1 infection in several types of human cell lines. FL cells and the T-cell line CCRF-CEM strongly
induced SOCS3 during HSV-1 infection. The virus rapidly propagated in both cell lines and produced a lytic infection. On the other hand, the
monocytic cell lines U937 and THP-1, and the B-cell line AKATA showed neither SOCS3 induction nor suppression of IFN-induced STAT1
phosphorylation during HSV-1 infection. These cell lines resulted in a persistent or prolonged infection, which continuously produced a low
titer of infectious virus. The induction of SOCS3 by HSV-1 should occur via STAT3 activation immediately after HSV-1 infection. SOCS3
induction was inhibited by the addition of a Jak3 inhibitor WHI-P131. Treatment with WHI-P131 or transfection of antisense
oligonucleotides specific for SOCS3 dramatically suppressed replication of HSV-1 in FL cells. The suppression of viral replication by WHI-
P131 was released in the presence of neutralizing anti-IFN-a and anti-IFN-h antibodies. In conclusion, suppression of IFN signaling by HSV-
1-induced SOCS3 is required for efficient replication and lytic infection of HSV-1. The SOCS3 induction varied among cell lines, indicating
that it is an important factor determining the cell type specificity of efficient HSV-1 replication.
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Cells have various defense mechanisms that protect them
from viral infection. Interferon (IFN) is induced by viral
infection and plays an important role in defending the host
cell from viral attack. When IFN binds to specific cell
surface receptors on the host cells, it promotes the antiviral
state through induction or activation of the 2V,5V-oligoade-
nylate synthetase (2-5AS)/RNase L system, the double-
stranded RNA-activated protein kinase (PKR), and the MxA
protein (Fujii, 1994; Samuel, 2001; Sen and Ransohoff,
1993). Signal transduction by IFN is mediated through the
JAK/STAT pathway which consists of janus kinases (JAK),0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.04.028
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domains of various receptors, and the STAT family proteins,
transcription factors that are activated through phosphoryla-
tion by JAK. The JAK/STAT pathway also transduces
various cytokine signals. There are four JAK proteins
(Jak1, Jak2, Jak3, and Tyk2) and seven STAT proteins
(STAT1 to 4, STAT5a, STAT5b, and STAT6) (Aaronson and
Horvath, 2002; Darnell et al., 1994; Leonard and O’Shea,
1998; O’Shea et al., 2002). Each cytokine employs a
particular combination of the JAK and STAT proteins, which
in turn determines the specificity of the cytokine responses.
For instance, Jak1 and Tyk2 are associated with the IFN-a/h
receptor complex. These JAK proteins are activated by
phosphorylation after IFN-a/h binds to its receptor, and they
phosphorylate STAT1 and STAT2. Phosphorylated STAT1
and phosphorylated STAT2 can bind to IRF-9/p48/ISGF3g,05) 173 – 181
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cates into the nucleus and binds to IFN-stimulated response
elements in the promoters of IFN-inducible genes (Darnell et
al., 1994; Goodbourn et al., 2000; Samuel, 2001).
According to recent reports, herpes simplex virus type 1
(HSV-1) suppresses the IFN signaling pathway at multiple
sites in order to evade host defense mechanisms. We reported
that IFN-induced JAK phosphorylation was inhibited in FL
cells during the early infection stages of HSV-1 (Yokota et al.,
2001) and suppressor of cytokine signaling-3 (SOCS3),
which is a host negative regulator of the JAK/STAT pathway,
was rapidly induced under these conditions (Yokota et al.,
2004b). The UL41 gene product (virion host shutoff protein)
contributes to IFN resistance (Suzutani et al., 2000). Chee and
Roizman (2004) reported that HSV-1-blocked-IFN signaling
in part by reduced levels of Jak1 and STAT2 proteins through
the action of the UL41 gene product. In addition, HSV-1
suppresses IFN production. Melroe et al. (2004) reported that
HSV-1 inhibited the production of IFN-h, which is partly
mediated by degradation of IFN regulatory factor 3 (IRF-3).
The immediate early protein ICP0 contributes to this. Lin et al.
(2004) reported that ICP0 inhibited IRF-3- and IRF-7-
mediated gene activation, including IFN-h production,
without degradation of proteins, such as IRF-3, CBP, and
TBK-1. They also showed that hyperphosphorylation of
IRF-3 did not occur during HSV-1 infection. In contrast, our
previous report showed that phosphorylation of IRF-3 and
induction of IFN-h mRNA occurred during HSV-1 infection
(Yokota et al., 2004b). Mogensen et al. (2004) reported that
production of proinflammatory cytokines, including IFN-a/h,
was suppressed byHSV-1, and the suppression was caused by
participation of the immediate early gene products, ICP4 and
ICP27. Suppression of IFN-induced effectors by HSV-1 has
been also reported. Phosphorylated eIF-2a, which shuts off
protein synthesis, is dephosphorylated by cooperation of viral
g134.5 protein and host protein phosphatase 1a (He et al.,
1997). So, the IFN-induced protein synthesis shutoff is
released by HSV-1. In addition to g134.5, the late gene
Us11 also contributes to IFN resistance (Mulvey et al., 2004).
Promyelocytic leukemia protein (PML), which forms nuclear
body ND10 and contributes to anti-viral activity, is degraded
by viral ICP0 (Chee et al., 2003; Everett et al., 1998).
Previously, we showed that SOCS3was rapidly induced in
FL cells by HSV-1 infection (Yokota et al., 2004b). The
induced SOCS3 protein reaches maximal levels around 1 to 2
h post-infection and inhibits IFN-induced phosphorylation of
JAK.We consider this event to be crucial in HSV-1 inhibition
of IFN system because it occurs most rapidly after infection
as compared to the strategies described above which should
take at least several hours to occur. The SOCS family proteins
are STAT-induced STAT inhibitors that provide negative
feedback regulation of the JAK/STAT pathway. These
proteins commonly share an N-terminal region of variable
length, a central src homology 2 (SH2) domain, and a C-
terminal SOCS box. SOCS proteins are generally expressed
at low levels in cells and their gene transcription is induced byvarious cytokines that activate the JAK/STAT pathway
(Alexander, 2002; Cooney, 2002; Krebs and Hilton, 2001;
Yasukawa et al., 2000). To date, eight SOCS family proteins
(SOCS1 to 7 and CIS) have been identified. Of these, SOCS1
and SOCS3 are reported to inhibit signal transduction by IFN
(Bode et al., 2003; He et al., 2003; Sen and Ransohoff, 1993;
Song et al., 1998; Yokota et al., 2004b). SOCS3 has been
reported to inhibit various cytokines including IFNs, such as
interleukin-1 (IL-1), IL-2, IL-3, IL-4, IL-6, growth hormone,
prolactin, insulin, oncostatin M, leptin, erythropoietin, and
ciliary neurotropic factor (Alexander, 2002; Cooney, 2002;
Krebs and Hilton, 2001; Yasukawa et al., 2000). SOCS3
associates with cytokine receptors and inhibits activation,
namely phosphorylation, of JAKs (Nicholson et al., 2000;
Schmitz et al., 2000). SOCS1 directly interacts with JAK and
inhibits their enzymatic activity (Yasukawa et al., 1999).
Our previous paper described induction of SOCS3 in FL
cells (Yokota et al., 2004b). Currently, it is unclear whether
the induction of SOCS3 by HSV-1 is general phenomenon
in other cell types or not. In the present study, we examined
SOCS3 induction in various cell lines and found that the
inducibility of SOCS3 was correlated with rapid viral
replication in the early stages of infection.Results
Inducibility of SOCS-3 by HSV-1 varies among cell lines
and correlates with viral replication
Previously, we described SOCS3 induction during HSV-
1 infection in FL cells (Yokota et al., 2004b). In the present
study, we examined the mRNA expression of JAK/STAT
negative regulators in various types of cell lines, in the
presence or absence of HSV-1 infection (Fig. 1A). FL and
CCRF-CEM showed a dramatic increase in SOCS3 mRNA
following virus infection (9.27-fold and 15.30-fold, respec-
tively). TALL-1 showed a weak increase (4.70-fold) upon
infection. U937, THP-1, and AKATA did not show any
SOCS3 induction. Protein expression levels of SOCS3 were
consistent with the results of semi-quantitative reverse
transcription-polymerase chain reaction (RT-PCR) (Fig.
1B). Induction of SOCS3 protein was also observed in FL
cells (4.46-fold compared to untreated control) and CCRF-
CEM cells (5.33-fold). TALL-1 showed very weak increase
(1.65-fold). However, the other cell lines express SOCS3
protein, under normal culture condition, they did not show
significant changes in SOCS3 protein levels. The basal
expression levels SOCS3 were 1.19 (TALL-1), 0.79 (CCRF-
CEM), 1.10 (AKATA), 1.05 (THP-1), and 1.47 (U937),
relative to level in FL cells, which was set as 1.00. The
quantitative values were mean values deduced from three
time experiments. CIS mRNAwas downregulated in TALL-
1 and CCRF-CEM and upregulated in THP-1 cells by HSV-
1 infection. SOCS1 mRNA was observed in AKATA and
U937 cells, and their expression levels did not change by
Fig. 1. Effect of HSV-1 infection on expression of SOCS family genes in various cell lines. (A) mRNA levels determined by RT-PCR. TALL-1, CCRF-CEM,
AKATA, THP-1, U937, and FL cells were infected with HSV-1 strain VR3 at an MOI of 5. After 1 h of infection, cells were harvested. Total cellular RNAwas
extracted and assessed by semi-quantitative RT-PCR using specific primer sets for detecting SOCS3, SOCS1, and CIS. GAPDH was carried out as a control.
The PCR products were analyzed by 2%(w/v) agarose electrophoresis. (B) Protein levels determined by Western blotting. Infected cells were harvested at
various times after infection as indicated for each lane. Cell lysates were assessed by Western blotting with an anti-SOCS3 antibody. h-tubulin was examined as
a control. Fifty micrograms and 5 Ag proteins were applied to SDS-PAGE for analysis of SOCS3 and h-tubulin, respectively.
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lated by HSV-1 infection in THP-1 cells. Neither SOCS1
nor CIS mRNA was detected in FL cells. Viral infection of
cells was determined by immunofluorescence microscopy.
All cells so far observed were positive for anti-HSV-1
antibody (Fig. 2). Consistent with the induction of SOCS3,
IFN-a-induced STAT1 phosphorylation was almost com-
pletely inhibited in FL and CCRF-CEM cells by HSV-1
infection (Fig. 3). The phosphorylation was partially
inhibited in TALL-1 cells and the inhibition was not
observed in U937, THP-1, and AKATA cells by HSV-1
infection (Fig. 3). In FL and CCRF-CEM cells, HSV-1
efficiently replicated (virus reached more than 107 pfu/ml in
culture medium during a few days of infection) and then
produced a lytic infection (Table 1). Cytopathic effects were
not observed in TALL-1. Only weak cytopathic effects were
observed in U937, THP-1, and AKATA. The latter four cell
lines produced low titers (about 104 to 105 pfu/ml) of
infectious virus in the culture medium, even though HSV-1
had infected all cells in the culture as observed by
immunofluorescence microscopy (Fig. 2). TALL-1, U937,
and THP-1 infected with HSV-1 were able to be maintained
by repetitive subculture, however, infected AKATA cells
died approximately 10 days after infection without high titer
virus production. These results suggest that HSV-1 rapidly
replicated and caused lytic infections in cells which strongly
induce SOCS3. In contrast, HSV-1 did not replicate
efficiently and produced a prolonged or persistent infectionwith low titer virus production in cells which showed weak
or little induction of SOCS3.
Suppression of SOCS3 expression by an antisense
oligonucleotide results in suppressed virus replication
To examine the contribution of SOCS3 to HSV-1
replication, we used an antisense oligonucleotide specific
for SOCS3. After transfection of SOCS3 antisense oligo-
nucleotide or its negative control oligonucleotide, cells were
challenged with the virus at an MOI of 1. The virus titers
after 24 h of infection were determined by the plaque-
forming assay. At high concentrations (500 nM) of
oligonucleotide, basal and HSV-1-induced levels of SOCS3
mRNA expression were efficiently suppressed (Fig. 4A).
Under these conditions, viral replication was dramatically
suppressed (about 103 pfu/ml reduction) (Fig. 4B). Control
oligonucleotides did not have such effect. Similar results
were observed for another high responder cell, CCRF-CEM.
However, CCRF-CEM showed relatively weak suppression
of SOCS3 expression and viral replication (about 102 pfu/ml
reduction) by transfection of antisense oligonucleotides
compared to FL cells (data not shown). This should be
due to less transfection efficacy in CCRF-CEM cells, which
were suspension cells, than in FL cells, which were adherent
cells. On the other hand, we observed that virus replication
in U937 and THP-1, which did not show SOCS3 induction
by HSV-1 infection, did not interfere by the transfection of
Fig. 2. Immunofluorescence microscopic analysis of the presence of virus
in cells infected with HSV-1. TALL-1, CCRF-CEM, AKATA, THP-1,
U937, and FL cells were infected with HSV-1 VR3 at an MOI of 5. After 24
h of infection, cells were fixed with methanol and stained with
fluorescence-labeled anti HSV-1 antibody. HSV-1 (+): HSV-1 infected
cells; (): uninfected control cells; upper panels: phase contrast; lower
panels: fluorescence.
Fig. 3. Effect of HSV-1 infection on IFN-a-induced STAT1 phosphorylation. TAL
HSV-1 strain VR3 at an MOI of 5. After 2 h of infection, cells were treated with 10
blotting using anti-Tyr-phosphorylated STAT1 (STAT1-pY) and anti-STAT1 antib
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results indicate that induction of SOCS3 by HSV-1 infection
contributed to the efficiency of viral replication.
Inhibition of Jak3 activation results in suppression of viral
replication
Expression of human SOCS3 is controlled by the
transcription factor, STAT3, as well as murine one (He et
al., 2003) . We observed that STAT3 was rapidly phospho-
rylated after HSV-1 infection in FL cells and CCRF-CEM
cells (Fig. 5). In contrast, THP-1 cells did not show
induction of SOCS (Fig. 1) and phosphorylation of STAT3
(Fig. 5) by HSV-1 infection. STAT3 is phosphorylated by
Jak3 and Jak3 is independent to IFN signaling, so we used
an inhibitor of Jak3 (WHI-P131) in order to suppress
SOCS3 expression. We confirmed that WHI-P131 did not
influence on IFN-a-induced phosphorylation of Jak1 and
Tyk2, and IFN-g-induced phosphorylation of Jak1 and Jak2
(data not shown). FL cells were pretreated with WHI-P131
for 30 min, and then virus challenged. WHI-P131 at a
concentration of 50 Ag/ml required for almost complete
suppression of basal and HSV-1-induced SOCS3 mRNA
levels, as detected by semi-quantitative RT-PCR (Fig. 6A)
and Western blotting (Fig. 6B). In the absence of WHI-
P131, HSV-1 infection blocked IFN-a-induced Jak1 phos-
phorylation. In the presence of WHI-P131, HSV-1 was no
longer able to suppress IFN-induced Jak1 phosphorylation,
although basal protein levels of Jak1 were significantly
decreased by WHI-P131 (Fig. 6C). Viral replication was
dramatically suppressed in the presence of WHI-P131 (Fig.
6D). The suppression by WHI-P131 was more clearly
observed in HSV-1 infection at an MOI of 1 than at an MOI
of 5. The negative control compound, WHI-P258, did not
show any effect on virus titer compared to controls.L-1, CCRF-CEM, AKATA, THP-1, U937, and FL cells were infected with
00 IU/ml IFN-a for 10 or 20 min. Cells were lysed and assessed by Western
odies. x in the U937 panel indicates non-specific bands.
Table 1
HSV-1 replication in various types of human cell lines
Day after infection TALL-1 CCRF-CEM AKATA THP-1 U937 FL
1 1.5  104 2.4  104 8.2  103 2.4  103 1.2  103 1.1  108
2 1.7  104 1.3  107 2.6  105 8.0  104 4.4  104 death
4 2.4  104 death 5.4  106 2.6  105 2.8  104
6 2.8  104 5.0  104 2.0  105 3.6  104
HSV-1 infections were at an MOI of 5. Culture medium was changed everyday. Virus titer in the collected culture supernatant was determined by a plaque-
forming assay using Vero cell as an indicator.
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THP-1, which did not show SOCS3 induction by HSV-1
infection, did not interfere by the addition of WHI-P131
(data not shown).
Neutralizing anti-IFN-a and anti-IFN-h antibodies were
added to cell cultures during HSV-1 infection in the
presence of WHI-P131. The neutralizing antibodies highly
and significantly released the inhibitory activity of the Jak3
inhibitor WHI-P131 on viral replication (Fig. 7). This
suggests that the suppressed viral replication by the Jak3
inhibitor should be caused by autologously produced IFN.
These results indicated that inhibition of the IFN system byFig. 4. Effect of SOCS3 antisense oligonucleotide on HSV-1 replication in
FL cells. Phosphorothioate oligonucleotides of specific antisense for human
SOCS3 and its mismatch control were transfected into FL cells. FL cell
cultures were transfected three times at intervals of 36 h. Cultures were
incubate for 48 h after the last transfection and then infected with HSV-1
VR3 at an MOI of 1. After 24 h of infection, virus titers in the culture
medium were determined by the plaque-forming assay. Each experiment
was carried out in triplicate and the data are present as mean T SD. Mock:
transfection with an unrelated plasmid. **P < 0.01 compared to control.virus-induced SOCS3 mainly contributes to efficient virus
replication.Discussion
We previously reported that HSV-1 infection upregulates
SOCS3, a host endogenous JAK/STAT inhibitor (Yokota et
al., 2004b). SOCS family proteins have been shown to
suppress various cytokine signaling through the JAK/STAT
pathway by a negative feedback regulation. SOCS3 inhibits
JAK phosphorylation, namely activation, by association
with cytokine receptors (Alexander, 2002; Nicholson et al.,
2000; Schmitz et al., 2000). To our knowledge, only two
reports suggesting virus-induced SOCS3 have been pub-
lished to date, our previous report (Yokota et al., 2004b) and
a report described by Bode et al. (2003). Bode et al.
demonstrated that human hepatitis C virus core protein
transcriptionally induced SOCS3 that suppresses the IFN-
induced anti-viral state. On the other hand, some IFN-
resistant leukemia and lymphoma cell lines constitutively
express SOCS3 (Brender et al., 2001; Sakai et al., 2002).
Expression of SOCS3 coincided with constitutive phos-
phorylation of STAT3 in these cell lines. These lines ofFig. 5. Activation of STAT3 by HSV-1 infection. FL cells, CCRF-CEM
cells and THP-1 cells were infected with HSV-1 VR3 at an MOI of 5. At
various times after infection, cells were lysed and assessed by Western
blotting with anti-Tyr-phosphorylated STAT3 (STAT3-pY) and anti-STAT3
antibodies.
Fig. 6. Effect of the Jak3 inhibitor WHI-P131 on HSV-1 replication in FL cells. (A) Suppression of SOCS-3 mRNA induction by WHI-P131 determined by RT-
PCR. FL cells were treated with 20 or 50 Ag/ml Jak3 inhibitor WHI-P131 or its control WHI-P258 for 30 min. FL cells were then infected with HSV-1 VR3 at
an MOI of 5 in the presence of WHI-P131 or WHI-P258. At various times after infection as indicated, total RNAwas isolated. mRNA levels of SOCS3 were
determined by semi-quantitative RT-PCR. GAPDH was carried out as a control. (B) Suppression of SOCS-3 protein induction by WHI-P131 determined by
Western blotting. After 90 min of infection with HSV-1 VR3 (MOI 5), FL cells were lysed and assessed by Western blotting with anti-SOCS3 antibody. Actin
was used as a control. (C) Effect of WHI-P131 on inhibition of IFN-a-induced Jak1 phosphorylation by HSV-1 infection. FL cells were treated with 50 Ag/ml
WHI-P131 for 30 min. Cells were then infected with HSV-1 VR3 at an MOI of 5 in the presence of WHI-P131. After 2 h of infection, cells were treated with
1000 IU/ml IFN-a for 15 min. Untreated controls for each step in the treatment were also examined. The cells were lysed and assessed Western blotting with
anti-Tyr-phosphorylated Jak1 (Jak1-P) and anti-Jak1 antibodies. (D) Effect of WHI-P131 on HSV-1 replication in FL cells. FL cells were treated with 50 Ag/ml
WHI-P131 or WHI-P258 for 30 min. Cells were then infected with HSV-1 VR3 at an MOI of 1 or 5 in the presence of WHI-P131 or WHI-P258. After 24 h of
infection, culture supernatants were collected and virus titer in the supernatants was determined by the plaque-forming assay. Each experiment was carried out
in triplicate and the mean T SD are presented. **P < 0.01.
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STAT3 and it efficiently inhibits IFN-a/h signaling.
We found that cells (FL and CCRF-CEM) which showed
strong induction of SOCS3 during HSV-1 infection become
lytic infection with rapid HSV-1 replication. Cells (TALL-1)
which showed weak SOCS3 induction and cells (U937,
THP-1, and AKATA) which did not show any significant
SOCS3 induction turned into persistent or prolongedFig. 7. Effect of neutralizing anti-IFN antibodies on inhibition of HSV-1
replication by the Jak3 inhibitor WHI-P131. FL cells were treated with anti-
IFN-a and anti-IFN-h antibodies and 50 Ag/ml WHI-P131 or WHI-P258
for 30 min. Cells were the infected with HSV-1 VR3 at an MOI of 1 in the
presence of 50 Ag/ml WHI-P131 or WHI-P258 and anti-IFN neutralizing
antibodies. After 24 h of infection, culture supernatants were collected and
virus titers in the supernatants were determined by the plaque-forming
assay. Untreated controls for each step in the treatment were also examined.
Each experiment was carried out in triplicate and the mean T SD are
presented. **P < 0.01 compared to untreated control.infection. Among these cell lines, only TALL-1 did not
show any cytopathic effects of HSV-1 and turned into a
persistent infection. Low HSV-1 replication in TALL-1
might be caused by weak induction of SOCS3, but TALL-1
cells could have additional unknown resistance mechanisms
against the cytopathic effects of HSV-1 and this remains to
be investigated. These are consistent with our previous
report describing the weaker induction of SOCS3 observed
by infection with tegument protein (UL41 or UL13)-
deficient mutant viruses compared with wild-type virus
(Yokota et al., 2004b). UL41 and UL13 contribute to the
hypersensitivity to IFN (Shibaki et al., 2001; Suzutani et al.,
2000). The poor induction of SOCS3 by these mutants may
be correlate with a lower replication efficiency (about one
log lower virus titer) compared to the parental virus (data
not shown). In order to confirm this relationship between
SOCS3 inducibility and viral replication, we examined the
effect of suppression of virus-induced SOCS3 on progeny
virus production in FL cells. The results of transfection with
antisense oligonucleotides specific for SOCS3 and treatment
with the Jak3 inhibitor WHI-P131 both indicate that
induction of SOCS3 is required for rapid replication of
HSV-1 during the early infection phase in FL cells. SOCS3
contributes to suppression of signal transduction of many
cytokines, including IFN, through a negative feedback
mechanism (Alexander, 2002; Cooney, 2002; Krebs and
Hilton, 2001; Yasukawa et al., 2000). Suppression of
SOCS3 is expected to lead to transduction of IFN-a/h
signaling by release of the negative feedback. To confirm
the effect of SOCS3 on IFN-induced suppression of viral
replication, we examined the effect of neutralizing anti-IFN-
a and anti-IFN-h antibodies on suppressed viral replication
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antibodies effectively released the suppression of viral
replication (Fig. 7). The results indicate that HSV-1
replication is suppressed by autologously produced IFN in
the absence of SOCS3. In some cell lines, HSV-1 is able to
induce SOCS3 expression in order to suppress the antiviral
activity of IFN. The neutralizing antibodies were only able
to partially recover the levels of viral replication and this
could be explained by the presence of other IFN species,
such as N and E, or other cytokine systems regulated by
SOCS3 which contribute to the SOCS3-mediated replica-
tion of the virus. These lines of evidence indicate that
induction of SOCS3 is a key factor in rapid virus replication
during acute infection. The major mechanism by which
SOCS3 mediates rapid replication is through suppression of
IFN-a/h signaling. Inducibility of SOCS3 varied among cell
types, and this may be a deciding factor between lytic
infection and persistent or prolonged infection.
Jak3 inhibitors have been examined for its potential in
therapeutic use for cancer and graft versus host disease
(Changelian et al., 2003; Malaviya et al., 1999; Sudbeck et
al., 1999). Furthermore, it has been reported that SOCS3
promotes Th2 development by inhibiting IL-12-mediated
STAT4 activation in T cells (Seki et al., 2003). Therefore,
Jak3 inhibitors are also being considered to treat allergic
diseases, such as asthma and atopic diseases (Wong and
Leong, 2004). Now, we propose that Jak3 inhibitors have
potentials of treatment for viral infection. It is an important
point that SOCS3 is very rapidly induced by HSV-1
infection compared to other anti-IFN strategies such as
disappearance of host proteins contributing to IFN produc-
tion and signal transduction as described in Introduction.
Jak3 inhibitors may suppress acute infection and rapid
propagation of HSV-1.Materials and methods
Cells and viruses
The human amnion cell line FL, the T lymphoblastoid
cell line CCRF-CEM, and the monocytic cell lines U937
and THP-1 were obtained from the American Type Culture
Collection (ATCC; Manassas, VA). The human T-cell
leukemia cell line TALL-1 was obtained from the Japanese
Collection of Research Bioresources (JCRB; Tokyo, Japan).
AKATA (an EBV-negative clone) was described previously
(Hariya et al., 1999). All cells were routinely cultured in
RPMI-1640 containing 10% fetal bovine serum. The HSV-1
strain VR3 was obtained from ATCC. Unless otherwise
mentioned, virus infection was performed at a multiplicity
of infection of 5 (MOI 5). After 1 h of infection, culture
medium was changed in order to remove residual virus in
the culture medium. Virus titers in the culture supernatant
were determined by a plaque-forming assay using Vero cells
as an indicator.Reagents
The Jak3 inhibitor (WHI-P131) and its negative control
compound (WHI-P258) were purchased from Calbiochem
(La Jolla, CA). The stock solutions of these compounds
were prepared in dimethyl sulfoxide (DMSO) as a solvent.
When the compounds were added to cultured cells, the
corresponding amount of DMSO was added to control
experiments. A sheep anti-leukocyte IFN-a antibody and a
rabbit anti-IFN-h antibody were purchased from Chemicon
(Temecula, CA) and Pepro Tech EC (London, United
Kingdom), respectively. IFN-neutralizing culture using the
neutralizing antibodies was performed as described pre-
viously (Yokota et al., 2004a). Briefly, 10 Al/ml of anti-
IFN-a antiserum and 5 Ag/ml of IFN-h monoclonal
antibody were added to the culture medium. For control
experiments, the same amount of an immunoglobulin G
derived from normal sheep and rabbit sera were added to
the culture media.
Transfection of antisense oligonucleotides
An antisense oligonucleotide specific for human SOCS3
was the phosphorothioate oligonucleotide 5V-GCAGCTGG-
GTGACTTTCTCA-3V. This is the sequence used by
Mahboubi et al. (2003). The mismatch control was the
phosphorothioate oligonucleotide 5V-TGAGAAAGT-
CAGGGAGCTGC-3V. To transfect FL cells with oligonu-
cleotides, cells were cultured to about 30% confluency and
then incubated with 100 or 500 nM phosphorothionate
oligonucleotide and Superfect reagent (Qiagen, Hilden,
Germany) according to the manufacturer’s instruction. Cell
cultures were transfected three times at intervals of 36 h. No
significant cytotoxicity was observed in the transfection
experiment. After an additional 48 h of culture, the cells
were infected with HSV-1 at an MOI of 1. After 24 h of
infection, the virus titer in the culture medium was
determined by a plaque-forming assay.
Immunofluorescence microscopy
Adherent cells cultured on coverslips or floating cell
smears were fixed with methanol at room temperature for 5
min, and then blocked with PBS containing 2% goat serum.
The cells were stained with fluorescein-conjugated goat
anti-HSV-1 antibody (Chemicon) and analyzed by fluores-
cence microscopy on an Olympus IX71 system (Olympus,
Tokyo, Japan).
Western blotting
Preparation of total cell lysates, SDS-polyacrylamide gel
electrophoresis, and Western blotting were carried out as
described previously (Yokota et al., 1999, 2001). Rabbit
anti-SOCS3 antibody was purchased from IBL (Gunma,
Japan). Rabbit anti-STAT1 and was purchased from Santa
S. Yokota et al. / Virology 338 (2005) 173–181180Cruz Biotechnology (Santa Cruz, CA). Mouse anti-STAT3
monoclonal antibody was purchased from Transduction
Laboratories (Lexington, KY). Rabbit anti-phospho-STAT3
(Tyr705) and anti-phospho-STAT1 (Tyr701) antibodies were
purchased from Cell Signaling (Beverly, MA). Rabbit anti-
Jak1 and anti-phospho Jak1 antibodies were purchased from
Upstate Biotechnology (Lake Placid, NY) and BioSource
(Camarillio, CA), respectively. Alkaline phosphatase-con-
jugated anti-rabbit or mouse immunoglobulin antibodies
(BioSource) were used as secondary antibody and bromo-
chloroindolylphosphate-Nitro blue tetrazolium was the
enzyme substrate for Western blotting.
Semi-quantitative RT-PCR
Total cellular RNA was prepared using an RNeasy
Mini kit (Qiagen). RT-PCR was performed with the
OneStep RT-PCR kit (Qiagen). The quantitative nature
of the PCR was validated by the linearity of the
determination curve at various concentrations of RNA.
The primer sets used to detect SOCS3, SOCS1, CIS and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA have been described elsewhere (Sakai et al.,
2002; Yokota et al., 2003, 2004a).Acknowledgment
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